What is siParadigm?
Founded in 2004 and headquartered in Pine Brook, New Jersey, siParadigm operates as a healthcare diagnostic informatics company. It offers a comprehensive suite of services including Disease-focused NGS, PCR, Cytogenetics/FISH, Flow Cytometry, and Morphology/IHC, complemented by Siportfolio correlated reporting. The company serves physicians, patients, and providers, aiming to enhance diagnostic accuracy and reporting efficiency within the healthcare ecosystem.
How much funding has siParadigm raised?
siParadigm has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for siParadigm?
Given siParadigm's large-scale late-stage funding context, this latest strategic investment is poised to accelerate its growth trajectory. The capital infusion will likely support further development of its advanced diagnostic informatics platform, expansion into new markets, and enhancement of its service offerings. This strategic financing signals strong investor confidence in siParadigm's business model and its capacity to innovate within the competitive healthcare diagnostics landscape.
See full siParadigm company page
